{"generation": 30, "stage": "population", "candidate_idx": 0, "weights": {"risk_aversion": 0.24999960000047008, "herd_behavior": 0.5699995440002509, "profit_driven": 0.17999985600007923}, "mean_reward": -0.17813033424699873, "std_reward": 0.0, "mean_abs_error": 0.17813033424699873, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.04, "abs_error": 0.17813033424699873, "reward": -0.17813033424699873, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive catalysts in the provided data and the stock's low beta reducing expected upside, a modest adjustment to align with the benchmark weight and manage concentration might be expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 1, "weights": {"risk_aversion": 0.19999980000020004, "herd_behavior": 0.56999943000057, "profit_driven": 0.22999977000023003}, "mean_reward": -0.16813033424699872, "std_reward": 0.0, "mean_abs_error": 0.16813033424699872, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.03, "abs_error": 0.16813033424699872, "reward": -0.16813033424699872, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive catalysts in the provided data and the stock's low beta reducing expected upside, a modest adjustment to align with the benchmark weight and manage concentration might be expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 2, "weights": {"risk_aversion": 0.19999980000020004, "herd_behavior": 0.56999943000057, "profit_driven": 0.22999977000023003}, "mean_reward": -0.16813033424699872, "std_reward": 0.0, "mean_abs_error": 0.16813033424699872, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.03, "abs_error": 0.16813033424699872, "reward": -0.16813033424699872, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive catalysts in the provided data and the stock's low beta reducing expected upside, a modest adjustment to align with the benchmark weight and manage concentration might be expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 3, "weights": {"risk_aversion": 0.20999985720001477, "herd_behavior": 0.539999632800038, "profit_driven": 0.24999951000062728}, "mean_reward": -0.17813033424699873, "std_reward": 0.0, "mean_abs_error": 0.17813033424699873, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.04, "abs_error": 0.17813033424699873, "reward": -0.17813033424699873, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663), the stock appears relatively stable but not growth-oriented. The fund's current holding is substantial relative to AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With negative asset growth (Gat=-0.024) and moderate volatility, a modest adjustment might be expected to align with the fund's scale and the stock's defensive profile, likely resulting in a small decrease or minimal change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 4, "weights": {"risk_aversion": 0.20792075090661732, "herd_behavior": 0.6138607002256821, "profit_driven": 0.17821755876888687}, "mean_reward": -0.16813033424699872, "std_reward": 0.0, "mean_abs_error": 0.16813033424699872, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.03, "abs_error": 0.16813033424699872, "reward": -0.16813033424699872, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive catalysts in the provided data and the stock's low beta reducing expected upside, a modest adjustment to align with the benchmark weight and manage concentration might be expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 5, "weights": {"risk_aversion": 0.20792075090661732, "herd_behavior": 0.6138607002256821, "profit_driven": 0.17821755876888687}, "mean_reward": -0.16813033424699872, "std_reward": 0.0, "mean_abs_error": 0.16813033424699872, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.03, "abs_error": 0.16813033424699872, "reward": -0.16813033424699872, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive catalysts in the provided data and the stock's low beta reducing expected upside, a modest adjustment to align with the benchmark weight and manage concentration might be expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 6, "weights": {"risk_aversion": 0.22999977000023003, "herd_behavior": 0.58999941000059, "profit_driven": 0.17999982000018}, "mean_reward": -0.17813033424699873, "std_reward": 0.0, "mean_abs_error": 0.17813033424699873, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.04, "abs_error": 0.17813033424699873, "reward": -0.17813033424699873, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive momentum or growth signals, and given the fund's high benchmark orientation and low turnover constraint, a modest adjustment to align with the benchmark weight is expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 7, "weights": {"risk_aversion": 0.23999979600013738, "herd_behavior": 0.5599995240003206, "profit_driven": 0.199999680000392}, "mean_reward": -0.17813033424699873, "std_reward": 0.0, "mean_abs_error": 0.17813033424699873, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.04, "abs_error": 0.17813033424699873, "reward": -0.17813033424699873, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive momentum or growth signals, and given the fund's high benchmark orientation and low turnover constraint, a modest adjustment to align with the benchmark weight is expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 8, "weights": {"risk_aversion": 0.21999978000022002, "herd_behavior": 0.5999994000006, "profit_driven": 0.17999982000018}, "mean_reward": -0.16813033424699872, "std_reward": 0.0, "mean_abs_error": 0.16813033424699872, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.03, "abs_error": 0.16813033424699872, "reward": -0.16813033424699872, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive momentum or growth signals, and given the fund's high benchmark orientation and low turnover constraint, a modest adjustment to align with the benchmark weight is expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 9, "weights": {"risk_aversion": 0.23999976000024, "herd_behavior": 0.57999942000058, "profit_driven": 0.17999982000018}, "mean_reward": -0.17813033424699873, "std_reward": 0.0, "mean_abs_error": 0.17813033424699873, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.04, "abs_error": 0.17813033424699873, "reward": -0.17813033424699873, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable but not highly growth-oriented component. The fund's current holding is relatively modest compared to its AUM, and with no extreme signals in recent volatility or volume, a slight adjustment towards the benchmark weight might be expected, likely resulting in a minimal normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 10, "weights": {"risk_aversion": 0.20792075090661732, "herd_behavior": 0.6138607002256821, "profit_driven": 0.17821755876888687}, "mean_reward": -0.16813033424699872, "std_reward": 0.0, "mean_abs_error": 0.16813033424699872, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.03, "abs_error": 0.16813033424699872, "reward": -0.16813033424699872, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive catalysts in the provided data and the stock's low beta reducing expected upside, a modest adjustment to align with the benchmark weight and manage concentration might be expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 30, "stage": "population", "candidate_idx": 11, "weights": {"risk_aversion": 0.22999977000023003, "herd_behavior": 0.58999941000059, "profit_driven": 0.17999982000018}, "mean_reward": -0.17813033424699873, "std_reward": 0.0, "mean_abs_error": 0.17813033424699873, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 630, "quarter": "NA", "permno": 81736, "date": "2016-01-01 00:00:00", "holding_t": 70.107154, "ticker": "RMD", "company": "RESMED INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0103525982245567, "x_herd_mean": 0.0090280272915204, "x_profit_mean": 0.3929906965358246, "overall_mean": 0.1374571073506339, "y_true": 0.13813033424699872, "pred": -0.04, "abs_error": 0.17813033424699873, "reward": -0.17813033424699873, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.337) and low beta (0.663) indicating lower systematic risk, alongside a small S&P 500 weight (0.000538), the stock appears to be a stable, low-volatility holding. The fund's current holding is substantial relative to its AUM, suggesting a significant existing exposure. With no strong positive momentum or growth signals, and given the fund's high benchmark orientation and low turnover constraint, a modest adjustment to align with the benchmark weight is expected, likely resulting in a small negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
